If you’ve had you ever heard a marijuana smoker describe their on top of a scale from someone to Snoop Dog (Lion? ), a new study from Western University or college is shedding some light about how specific doses of the actual drug might affect serotonin levels differently or on benefits of marijuana. Read more at http://medicalmarijuanahelp.com/
In other phrases, the feeling of paranoia often associated with smoking marijuana.
Medical marijuana states
for the case in point, could be directly tied to the volume of the drug affecting some receptor in the mental faculties, according to the study by simply Dr. Steven Laviolette, a professor from the Departments of Anatomy and also Cell Biology and Psychiatry, and also his colleagues from Western’s Craving Research Group. Click here to read more info about Medical marijuana States.
Low doses of the marijuana-like drug
Published online recently from the Journal of Neuroscience- marijuana dispensaries, the learning shows that low doses of the marijuana-like drug in animal models can develop a “hyper-emotional state” much like that found in people being affected by paranoid thought processes. With the other end of the actual scale, medical marijuana strains study found that high doses produce the contrary effect — a “flat-lining of the emotional response” he claimed is analogous to what could trigger the behavior of some stereotypically disinterested and apathetic stoner.
Psychological effects What we found is these effects on emotion were because of the ability of the substance to either ramp up or turn off the dopamine neurons in the brain according to the dose. Through these findings, we identify the brain’s prefrontal cortex being a critical brain region intended for controlling marijuana-induced disturbances in emotional processing via a direct (manipulation) of the actual brain’s dopamine system. ”
Element of the marijuana plant
The analysis was conducted with rats using a synthetic cannabinoid (a class of chemical compounds that includes THC, the famous component of the marijuana plant) referred to as Win-55. It binds very selectively with a particular cannabinoid receptor, which made it easier for the research team to focus on the brain’s cannabinoid method.
Interestingly, the study team was also in a position to reverse the effects connected with low and high dosages of Win-55 using anti-psychotic drugs, which it believes has implications for medical marijuana users interested in eliminating some the side effects of the actual drug.
There’re thousands of patients that make use of medical marijuana now. Ultimately what we want to do is develop a safer type of a drug that’s resulting from marijuana that can produce each of the beneficial effects without producing most of these undesirable side effects as well as benefits of marijuana.
I think what the learning shows are that you can do this by targeting specific receptor systems that might be secondary to the outcomes of marijuana. Weed contains over 70 diverse chemicals, not these all have been fully known.
We are really just scratching the surface with regards to understanding what all of those different compounds within the actual raw plant itself are capable of doing. Medical marijuana states lab can be studying THC and a different compound called Cannabidiol, which researchers believe has therapeutic qualities that could be useful in treating some psychiatric conditions. We’re ultimately trying to tease apart these diverse chemicals, first of all (to) work out how they’re acting in serotonin levels medical marijuana strains.